According to our (Global Info Research) latest study, the global Automated Tissue Processor market size was valued at US$ 782 million in 2025 and is forecast to a readjusted size of US$ 1257 million by 2032 with a CAGR of 6.9% during review period.
In 2025, global Automated Tissue Processor production reached approximately 20,000 units, with an average global market price of around USD 38,000 per unit.
The gross profit margin of major companies in the industry is between 40%–55%.
In 2025, the global production capacity of Automated Tissue Processor was approximately 26,000 units.
Automated Tissue Processor is a laboratory pathology instrument designed to automatically process biological tissue samples through fixation, dehydration, clearing, and paraffin infiltration procedures before histological examination. The system improves workflow efficiency, reduces manual operation errors, and ensures consistent sample preparation quality. It is mainly used in hospitals, pathology laboratories, medical research institutions, and diagnostic centers. The product scope includes fully automated tissue processing systems while excluding manual tissue processing equipment and standalone staining instruments.
The industry chain includes upstream suppliers of precision mechanical components, pumps, heating modules, control systems, sensors, and laboratory consumables. Midstream covers instrument design, assembly, software integration, calibration, and quality testing. Downstream applications include pathology laboratories, hospitals, diagnostic centers, medical universities, and research institutions requiring automated sample preparation.
This report is a detailed and comprehensive analysis for global Automated Tissue Processor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Automated Tissue Processor market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Automated Tissue Processor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Automated Tissue Processor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Automated Tissue Processor market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Automated Tissue Processor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Automated Tissue Processor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Leica Biosystems, Epredia, Sakura Finetek Japan Co., Ltd., Thermo Fisher Scientific Inc., Milestone Srl, Agilent Technologies, Inc., MEDITE Medical GmbH, SLEE medical GmbH, Diapath S.p.A., AMOS Scientific Pty Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Automated Tissue Processor market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vacuum-Based Processor
Pressure-Based Processor
Microwave-Assisted Processor
Market segment by Control Architecture
Standalone Control System
PC-Based Control System
Networked LIS-Integrated System
Market segment by Specimen Capacity
≤150 Cassettes
151–300 Cassettes
> 300 Cassettes
Market segment by Application
Hospital Pathology Laboratories
Independent Pathology Laboratories
Research Institutes
Other
Major players covered
Leica Biosystems
Epredia
Sakura Finetek Japan Co., Ltd.
Thermo Fisher Scientific Inc.
Milestone Srl
Agilent Technologies, Inc.
MEDITE Medical GmbH
SLEE medical GmbH
Diapath S.p.A.
AMOS Scientific Pty Ltd.
General Data Healthcare, Inc.
Hubei Taikang Medical Equipment Co., Ltd.
Zhejiang Jinhua Yidi Medical Appliance Co., Ltd.
Dakewe Medical Technology Co., Ltd.
Wuhan Jiyuan Medical Technology Co., Ltd.
Changzhou Zhongwei Electronic Instrument Co., Ltd.
Guangdong Haichuang Medical Technology Co., Ltd.
Hunan Huarui Medical Technology Co., Ltd.
Histo Scientific Instrument (China) Co., Ltd.
Beijing Zhixin Medical Technology Co., Ltd.
Shenyang Longshou Electronic Instrument Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Automated Tissue Processor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Automated Tissue Processor, with price, sales quantity, revenue, and global market share of Automated Tissue Processor from 2021 to 2026.
Chapter 3, the Automated Tissue Processor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Automated Tissue Processor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Automated Tissue Processor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Automated Tissue Processor.
Chapter 14 and 15, to describe Automated Tissue Processor sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Automated Tissue Processor. Industry analysis & Market Report on Automated Tissue Processor is a syndicated market report, published as Global Automated Tissue Processor Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Automated Tissue Processor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.